| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Revenue | $759.2M | +30.9% |
| Cost of Revenue | $85.1M | +42.6% |
| Gross Profit | $674.1M | +29.6% |
| R&D Expense | $239.7M | +19.3% |
| SG&A Expense | $192.9M | +28.2% |
| Operating Income | -$142.7M | +23.9% |
| Pre-tax Income | -$85.8M | +46.4% |
| Income Tax | -$76.7M | -129.0% |
| Net Income | -$6.3M |
| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $227.6M | -21.0% |
| Accounts Receivable | $264.6M | +58.7% |
| Current Assets | $1.34B | +4.3% |
| Total Assets | $1.40B | +6.2% |
| Current Liabilities | $545.0M | -17.7% |
| Total Liabilities | $578.0M | -17.4% |
| Stockholders' Equity | $775.9M | +35.8% |
| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$64.0M | -282.6% |
| Capital Expenditures | $3.8M | +135.6% |
| Investing Cash Flow | -$30.5M | +64.6% |
| Financing Cash Flow | $32.6M | -27.9% |
| Free Cash Flow | -$67.7M | -302.5% |
| +98.5% |
| EPS (Basic) | -$0.04 | +98.5% |
| EPS (Diluted) | -$0.04 | +98.5% |